Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2003
08/12/2003US6605623 Prevention of asthma and other allergic diseases
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605614 [1,8] naphthyridine derivatives having antiviral activity
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/07/2003WO2003064432A1 Process for total synthesis of ecteinascidins and intermediates therefor
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064422A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
08/07/2003WO2003064421A1 Aminopiperidine derivatives
08/07/2003WO2003064415A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003WO2003064414A1 Tricyclic compounds useful as angiotensin ii agonists
08/07/2003WO2003064413A1 Quinazoline compounds
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063864A2 Heterocyclic compounds which are active as inhibitors of beta lactamases
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003US20030149268 Administering non-steroidal 9-pyrido(3,2-g)quinoline compounds to the mammal for affecting androgen receptor activity
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/07/2003US20030149071 Pyrido [2,1-a] isoquinoline derivatives
08/07/2003US20030149067 Crystallisation of the desired crystalline form from a toluene/diethyl ether mixture comprising raw cabergoline, followed by recovery and drying of the resulting crystals
08/07/2003US20030149065 Arylkylamine spirofuropyridines useful in therapy
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149044 Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
08/07/2003US20030149042 For prophylaxis and therapy of pain or nociception
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149017 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
08/07/2003US20030149014 Imidazo[4,5-b]-pyridinium-containing cephem compounds having broad antibacterial spectrum activity
08/07/2003US20030149001 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/07/2003CA2474850A1 Imidazo[1,2-a]pyridine derivatives
08/07/2003CA2474718A1 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/06/2003EP1333031A1 Bicyclic triazolone derivatives and herbicides containing the same
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332144A1 Indole derivatives as pde5-inhibitors
08/06/2003EP1332143A1 Polysubstituted imidazopyridines as gastric secretion inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1331937A2 Dibenzoxazepine alpha v integrin receptor antagonist
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434714A Method and composition for the treatment of pain
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117080C Method for producing (hetero) aromatic hydroxylamines
08/05/2003US6603041 Inhibit binding of integrins to their ligands and are of use in prophylaxis and therapy of of immune or inflammatory disorders, or disorders including inappropriate growth or migration of cells
08/05/2003US6603003 Method for the preparation of piperazine and its derivatives
08/05/2003US6602882 Quinoline derivatives and their use as antibacterial agents
08/05/2003US6602881 Anti-inflammatory uses of manzamines
08/05/2003US6602880 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602868 Administering a heterocyclic amine or a phenylazacycloalkane
08/05/2003US6602866 Mercaptoacetylamide derivatives, a process for their preparation and their use
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602826 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/05/2003CA2088798C Condensed imidazopyridine derivatives
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062238A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
07/31/2003WO2003062237A1 White light emitting compound, white light emission illuminator, and white light emission organic el device
07/31/2003WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062204A1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
07/31/2003WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003WO2003061657A1 5-ht3 receptor antagonists and methods of use
07/31/2003WO2003061388A1 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method of controlling weed with the same
07/31/2003WO2003057698A3 Spiroazacyclic compounds as monoamine receptor modulators
07/31/2003WO2003039460A3 Mitotic kinesin inhibitors
07/31/2003WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
07/31/2003US20030144518 Reacting an isonitrile resin with an aldehyde having the formula R1CHO and a substituted or unsubstituted 2-aminopyridine in the presence of an acid catalyst to form a resin bound 2-substituted-3-aminoimidazo(1 ,2-a)pyridine; and
07/31/2003US20030144517 Chiral fluoroquinolone arginine salt forms
07/31/2003US20030144515 Process for making spirolactone compounds
07/31/2003US20030144509 Prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients.
07/31/2003US20030144507 Sulfonamide-containing heterocyclic compounds
07/31/2003US20030144502 Induce apoptosis; anticancer agents
07/31/2003US20030144323 Phenylalkynes
07/31/2003US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics
07/31/2003US20030144307 2,6-Disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease
07/31/2003US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis
07/31/2003US20030144283 Amide substituted imidazoquinolines
07/31/2003US20030144277 Piperizinones as modulators of chemokine receptor activity
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same